IDEX Biometrics extraordinary general meeting held on 19 June 2024
June 19 2024 - 8:30AM
UK Regulatory
IDEX Biometrics extraordinary general meeting held on 19 June 2024
IDEX Biometrics ASA held an extraordinary general meeting on 19
June 2024. 97.2 million shares or 31.6% of the share capital was
represented at the meeting.
Item 6 on the agenda, Board, was withdrawn because the
nomination committee had not put forward any proposals.
All other resolutions were passed as proposed by the board, with
an update as regards dates in item 4 on the agenda, Subsequent
offering.
At agenda item 3, Private placement; Issue of Tranche 2 shares,
the extraordinary general meeting resolved to issue 5,393,120
shares at NOK 1.65 per share in Tranche 2 of the private placement
on 15 May 2024. Following the issue of the Tranche 2 shares, the
Company’s share capital is NOK 47,018,983.20 divided into
313,459,888 shares each with a nominal value of NOK 0.15 per share
and issued in name.
The change of dates at agenda item 4, Subsequent offering, was
caused by the Norwegian Financial Surveillance Authority’s approval
schedule for the forthcoming prospectus. Paragraph 4 of the
resolution on agenda item 4 reads: The subscription period for the
Subsequent Offering will commence on 22 August 2024 and end on 5
September 2024 at 16:30 hrs (CET) or at such later date as
determined by the Board, but not later than commencing 23 September
2024 and ending on 7 October 2024. In the event that the Prospectus
related to the Subsequent Offering has not been approved by the FSA
by the end of 21 August 2024, the subscription period will commence
on the first trading day on Oslo Børs following FSA approval and no
later than 23 September 2024 and end at 16:30 hrs (CET) 14 calendar
days later. The more detailed criteria for subscription will be
determined by the Board and described in the prospectus.
At agenda item 5 Issue of warrants, the extraordinary general
meeting resolved to issue warrants to investors participating in
the Private Placement (both Tranche 1 and Tranche 2) and the
Subsequent Offering. The number of warrants which may be issued
shall be one warrant for each share subscribed for and allocated in
the Private Placement or the Subsequent Offering. The exercise
price is NOK 1.65. The maximum number of warrants that may be
issued is 41,333,333.
For further information contact:
Marianne Bøe, Head of investor relations
E-mail: marianne.boe@idexbiometrics.com
Tel: +47 918 00186
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in
fingerprint biometrics, offering authentication solutions across
payments, access control, and digital identity. Our solutions bring
convenience, security, peace of mind and seamless user experiences
to the world. Built on patented and proprietary sensor
technologies, integrated circuit designs, and software, our
biometric solutions target card-based applications for payments and
digital authentication. As an industry-enabler we partner with
leading card manufacturers and technology companies to bring our
solutions to market.
For more information, visit www.idexbiometrics.com
About this notice
This notice was issued by Erling Svela, Vice president of finance,
on 19 June 2024 at 14:30 CET on behalf of IDEX Biometrics ASA. This
information is subject to disclosure pursuant to Euronext Oslo Børs
rule book, and also section 5‑8 of the Norwegian Securities Trading
Act (STA) and published in accordance with section 5‑12 of the
STA.
Idex Biometrics Asa (LSE:0MTP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Idex Biometrics Asa (LSE:0MTP)
Historical Stock Chart
From Jul 2023 to Jul 2024